PATENT CLAIM ANALYSIS

Application Number: 16237893
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-04
Patent Classification: ["530", "326000"]

Abstract:
The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Claim (Index 9):
The C5 inhibitor polypeptide of  claim 8 , wherein the bridging moiety comprises a structure selected from the group consisting of structures I-XIX; wherein each X is independently N or CH, such that no ring contains more than 2 N; each Z is independently a bond, NR, O, S, CH 2 , C(O)NR, NRC(O), S(O) v NR, NRS(O) v ; each m is independently selected from 0, 1, 2, and 3; each v is independently selected from 1 and 2; each R is independently selected from H and C 1 -C 6 ; and each bridging moiety is connected to the polypeptide by independently selected C 0 -C 6  spacers.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.17647
- Patent Class: 530.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16128561', '15318063', '15905158', '15547085', '14962457']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8306462094234406
- 35 USC 102 Novelty (BERT): 0.6293758264361833
- Combined Prediction Score: 0.8105191711247149
- Mean Citation Score: 504.10272
- Max Citation Score: 611.3871
- Similarity Product: 508.84779437769066

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test